Literature DB >> 9870451

Methicillin-resistant Staphylococcus aureus (MRSA) infection in glomerulonephritis--a novel hazard emerging on the horizon.

M Kobayashi, A Koyama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9870451     DOI： 10.1093/ndt/13.12.2999

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  5 in total

1.  Glomerulonephritis induced by methicillin-resistant Staphylococcus aureus infection that progressed during puerperal period.

Authors:  Motomu Hashimoto; Fumiaki Nogaki; Emi Oida; Misa Tanaka; Toshiko Ito-Ihara; Keiko Nomura; Ning Liu; Eri Muso; Atsushi Fukatsu; Toru Kita; Takahiko Ono
Journal:  Clin Exp Nephrol       Date:  2007-03-28       Impact factor: 2.801

Review 2.  Staphylococcus aureus Infection-Related Glomerulonephritis with Dominant IgA Deposition.

Authors:  Mamiko Takayasu; Kouichi Hirayama; Homare Shimohata; Masaki Kobayashi; Akio Koyama
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

Review 3.  Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis.

Authors:  Anjali A Satoskar; Samir V Parikh; Tibor Nadasdy
Journal:  Nat Rev Nephrol       Date:  2019-08-09       Impact factor: 28.314

4.  Infection-Associated Peripheral Nerve Hyperexcitability: An Under-Recognized Entity.

Authors:  Ajith Sivadasan; Aditya Nair; Angel Miraclin; Arun Mathai Mani; A T Prabhakar; John Antony Jude Prakash; Vivek Mathew
Journal:  Ann Indian Acad Neurol       Date:  2021-04-28       Impact factor: 1.383

5.  Glomerulonephritis causing acute renal failure during the course of bacterial infections. Histological varieties, potential pathogenetic pathways and treatment.

Authors:  Jorge I Zeledon; Robin L McKelvey; Karen S Servilla; Diedre Hofinger; Konstantin N Konstantinov; Suzan Kellie; Yijuan Sun; Larry W Massie; Michael F Hartshorne; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.266
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.